|
Nutrition 21, Inc. - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Nutrition 21, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Nutrition 21, Inc.. The Group's principal activity is to develop market and distribute clinically substantiated nutritional supplements. These products are targeted for age and weight-related health needs, including diabetes, cardiovascular health, obesity, mental health, cognitive function and joint health. The products include Chromax which sells chromium picolinate to vitamin and supplement manufacturers and marketers and directly to retailers for its patented uses in human and animal nutrition products. The Group's trademarks include Chromax, Diachrome, Selenomax, SelenoPure, Zinmax, Zenergen and Magnemax. The Group operates in the United States.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|